Skip to main content

One in Five Children Globally Has Excess Weight

Medically reviewed by Carmen Pope, BPharm. Last updated on June 12, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, June 11, 2024 -- One in five children or adolescents globally experience excess weight, according to a study published online June 10 in JAMA Pediatrics.

Xinyue Zhang, Ph.D., from Sichuan University in Chengdu, China, and colleagues conducted a systematic literature review to estimate worldwide prevalence of overweight and obesity in children and adolescents from 2000 to 2023 and to assess potential risk factors for and comorbidities of obesity.

Based on 2,033 studies (154 different countries or regions; 45.9 million individuals), the researchers found that the overall prevalence of obesity in children and adolescents was 8.5 percent. Prevalence varied across countries, ranging from 0.4 percent (Vanuatu) to 28.4 percent (Puerto Rico). Countries with Human Development Index scores of ≥0.8 and high-income countries or regions had a higher prevalence of obesity among children and adolescents. There was a 1.5-fold increase in the prevalence of obesity in 2012 to 2023 compared with 2000 to 2011. A high risk for depression and hypertension was seen in children and adolescents with obesity. The pooled estimate of overweight was 14.8 percent and excess weight was 22.2 percent in children and adolescents.

"Excess weight among children and adolescents was associated with a mix of inherent, behavioral, environmental, and sociocultural influences that need the attention and committed intervention of primary care professionals, clinicians, health authorities, and the general public," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

Self-Administered Gerocognitive Exam Improves Detection of Cognitive Issues in Primary Care

TUESDAY, July 2, 2024 -- A self-administered gerocognitive examination (SAGE) is easily incorporated into primary care provider (PCP) visits, and its use significantly increases...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.